LifeCycle initiates phase I clinical trial of sirolimus for organ rejection after transplantation Dec. 3, 2007
Kiadis to provide Rhitol to physicians participating in phase I/II trial closed for enrollment Nov. 27, 2007
FDA grants orphan drug designation to Kiadis Pharma's ATIR for graft-versus-host disease Nov. 12, 2007
RSS